資金動向 | 北水減倉港股,騰訊、阿里、美團被賣出,買入信達生物超7億
8月13日,港股大升之際,南下資金淨賣出港股82.77億港元。
其中,淨買入信達生物7.09億、理想汽車-W 3.66億、鴻騰精密2.34億、小米集團-W 1.75億。
淨賣出盈富基金68.5億、恒生中國企業23.11億、騰訊控股2.5億、阿里巴巴-W 2.43億、美團-W 1.88億。
據統計,南下資金已連續5日淨買入小米,共計33.1711億港元。

北水關注個股
信達生物今日升8.82%。阿里健康與信達生物簽署戰略合作協議,雙方將在診後疾病管理、供應鏈、數字化營銷等多個領域展開深度合作。
理想汽車今日升3.3%,理想汽車創始人李想發文表示,9月目標之一:理想i8交付超越8000,挑戰一萬。
騰訊控股今日升4.74%,騰訊盤後發佈二季度業績,二季度營收達1845.04億元,同比增長14.5%;淨利潤為556.28億元,同比增長16.8%;每股收益為5.996元,上年同期為4.994元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.